melatonin has been researched along with Cystadenocarcinoma in 1 studies
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Except for melatonin, all neuroendocrine hormones used in this study inhibited proliferation of KF cells derived from human serous cystadenocarcinoma of the ovary in a dose-dependent manner." | 3.67 | Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones. ( Iwano, I; Kato, K; Kikuchi, Y; Kita, T; Miyauchi, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, Y | 1 |
| Kita, T | 1 |
| Miyauchi, M | 1 |
| Iwano, I | 1 |
| Kato, K | 1 |
1 other study available for melatonin and Cystadenocarcinoma
| Article | Year |
|---|---|
Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones.
Topics: beta-Endorphin; Cell Division; Cystadenocarcinoma; DNA, Neoplasm; Dose-Response Relationship, Drug; | 1989 |